ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,965Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 26

$937K Total Retail Price of All Prescriptions

Rank: 1 out of 26

547 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 547 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

6% of this provider’s 547 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 17,555 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 1,150 1,033 1 10
SIMVASTATIN 805 711 2 5
METOPROLOL TARTRATE 791 740 3 4
LISINOPRIL 745 679 4 2
AMLODIPINE BESYLATE 636 598 5 1
OMEPRAZOLE 591 484 6 9
TRAZODONE HCL 591 534 6 19
FUROSEMIDE 581 510 8 3
SERTRALINE HCL 553 485 9 20
LEVOTHYROXINE SODIUM 471 450 10 14
PRAVASTATIN SODIUM 313 285 11 24
MIRTAZAPINE 307 298 12 35
CITALOPRAM HBR 277 257 13 23
METOPROLOL SUCCINATE 275 219 14 16
HYDROCHLOROTHIAZIDE 254 250 15 8
DONEPEZIL HCL 229 218 16 36
NAMENDA 210 198 17 41
ATORVASTATIN CALCIUM 207 165 18 18
GABAPENTIN 199 155 19 26
LOSARTAN POTASSIUM 189 189 20 6
ALENDRONATE SODIUM 182 168 21 37
QUETIAPINE FUMARATE 180 177 22 48
DIOVAN 178 171 23 12
POLYETHYLENE GLYCOL 3350 166 158 24 51
LANTUS 156 140 25 53
TAMSULOSIN HCL 154 138 26 34
MELOXICAM 149 119 27 55
CARVEDILOL 149 142 27 28
DIGOXIN 148 131 29 43
ATENOLOL 147 144 30 15
RANITIDINE HCL 142 125 31 44
IPRATROPIUM-ALBUTEROL 140 134 32 58
GLIPIZIDE 138 118 33 42
HYDROCODONE-ACETAMINOPHEN 137 99 S3 34 33
DOXAZOSIN MESYLATE 135 120 35 7
ESCITALOPRAM OXALATE 120 99 36 60
TRAMADOL HCL 115 106 37 62
PREDNISONE 114 76 38 17
METFORMIN HCL 109 106 39 50
SPIRIVA 104 95 40 63
CLOPIDOGREL 103 93 41 49
CYMBALTA 102 91 42 64
RISPERIDONE 100 95 43 65
OLANZAPINE 97 92 44 68
KLOR-CON M20 95 89 45 45
PAROXETINE HCL 93 69 46 69
ADVAIR DISKUS 92 81 47 70
LEVETIRACETAM 88 72 48 71
CRESTOR 86 63 49 52
OXYCODONE-ACETAMINOPHEN 86 73 S2 49 72
LEVOFLOXACIN 86 77 49 72
ISOSORBIDE MONONITRATE ER 82 81 52 39
DIVALPROEX SODIUM 81 67 53 76
LATANOPROST 78 78 54 77
TAMIFLU 76 74 55 78
LIDODERM 75 51 56 79
FENOFIBRATE 75 62 56 79
GLIPIZIDE ER 74 74 58 81
VENLAFAXINE HCL ER 74 74 58 81
VENLAFAXINE HCL 68 68 60 83
POTASSIUM CHLORIDE 67 57 61 55
EXFORGE 65 65 62 88
LIPITOR 65 42 62 88
NOVOLOG 65 36 62 88
OXYBUTYNIN CHLORIDE ER 64 59 65 91
LOVASTATIN 64 64 65 91
CIPROFLOXACIN HCL 64 56 65 91
DILTIAZEM 24HR CD 64 64 65 91
PROAIR HFA 63 40 69 95
FLUTICASONE PROPIONATE 63 49 69 95
TIMOLOL MALEATE 62 62 71 97
TRIAMTERENE-HCTZ 61 49 72 99
LOSARTAN-HYDROCHLOROTHIAZIDE 61 50 72 99
FLOVENT HFA 59 36 74 101
PLAVIX 58 56 75 104
QUINAPRIL HCL 58 58 75 27
EXELON 58 58 75 104
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 50 78 29
HYDRALAZINE HCL 57 57 78 32
FOSINOPRIL SODIUM 56 45 80 108
FENTANYL 56 52 S2 80 108
OXYCODONE HCL 55 45 S2 82 110
BRIMONIDINE TARTRATE 55 55 82 110
OXYCONTIN 55 49 S2 82 110
HUMALOG 53 48 85 114
ALBUTEROL SULFATE 52 48 86 115
ALLOPURINOL 51 45 87 13
CLOZAPINE 51 23 87 119
GENERLAC 51 46 87 119
AZITHROMYCIN 51 43 87 119
GLIPIZIDE-METFORMIN 50 50 91 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.